{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:02:21Z","timestamp":1793678541188,"version":"4.5.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MC056"],"award-info":[{"award-number":["ZR2020MC056"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["LYL-SZ201915"],"award-info":[{"award-number":["LYL-SZ201915"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.saa.2021.120595","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T11:51:09Z","timestamp":1636977069000},"page":"120595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"P2","title":["Heparin interacts with the main protease of SARS-CoV-2 and inhibits its activity"],"prefix":"10.1016","volume":"267","author":[{"given":"Jinwen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.saa.2021.120595_b0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"2020","key":"10.1016\/j.saa.2021.120595_b0010","first-page":"727","article-title":"China novel coronavirus investigating and research team, a novel coronavirus from patients with pneumonia in China","volume":"382","author":"Zhu","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7798","key":"10.1016\/j.saa.2021.120595_b0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.saa.2021.120595_b0020","doi-asserted-by":"crossref","unstructured":"R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, N. Zhu, Y. Bi, X. Ma, F. Zhan, L. Wang, T. Hu, H. Zhou, Z. Hu, W. Zhou, L. Zhao, J. Chen, Y. Meng, J. Wang, Y. Lin, J. Yuan, Z. Xie, J. Ma, W. J. Liu, D. Wang, W. Xu, E.C. Holmes, G.F. Gao, G. Wu, W. Chen, W. Shi, W. Tan, Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet 395 (2020) 565\u2013574, doi: 10.1016\/S0140-6736(20)30251-8.","DOI":"10.1016\/S0140-6736(20)30251-8"},{"issue":"7811","key":"10.1016\/j.saa.2021.120595_b0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"6489","key":"10.1016\/j.saa.2021.120595_b0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"5626","key":"10.1016\/j.saa.2021.120595_b0035","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CL pro) structure: basis for design of an-ti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"issue":"6497","key":"10.1016\/j.saa.2021.120595_b0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.saa.2021.120595_b0045","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1039\/C4NP00076E","article-title":"Chemoenzymatic synthesis of heparan sulfate and heparin","volume":"31","author":"Liu","year":"2014","journal-title":"Nat. Prod. Rep."},{"issue":"11","key":"10.1016\/j.saa.2021.120595_b0050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1160\/TH08-01-0032","article-title":"Heparin and low-molecular-weight heparin","volume":"99","author":"Gray","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.saa.2021.120595_b0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/glycob\/5.1.83","article-title":"Preparation and structural characterization of large heparin derived oligosaccharides","volume":"5","author":"Pervin","year":"1995","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.saa.2021.120595_b0060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0959-440X(00)00257-8","article-title":"Order out of complexity\u2013protein structures that interact with heparin","volume":"11","author":"Mulloy","year":"2001","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.saa.2021.120595_b0065","doi-asserted-by":"crossref","unstructured":"N. Tang, H. Bai, X. Chen, J. Gong, D. Li, Z. Sun, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J. Thromb. Haemost. 18 (2020) 1094\u20131099, doi: 10.1111\/jth.14817.","DOI":"10.1111\/jth.14817"},{"key":"10.1016\/j.saa.2021.120595_b0070","doi-asserted-by":"crossref","unstructured":"B. Dixon, R. Smith, A. Artigas, Can nebulised heparin reduce time to extubation in SARSCoV2 the CHARTER study protocol, medRxiv (2020), doi: 10.1101\/2020.04.28.20082552.","DOI":"10.1101\/2020.04.28.20082552"},{"issue":"3","key":"10.1016\/j.saa.2021.120595_b0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/bph.15304","article-title":"Un-fractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations","volume":"178","author":"Tree","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.saa.2021.120595_b0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"issue":"9","key":"10.1016\/j.saa.2021.120595_b0085","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1021\/jp2108279","article-title":"Interaction of presequence with human translocase of the inner membrane of mitochondria Tim50","volume":"116","author":"Zhang","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.saa.2021.120595_b0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijbiomac.2021.06.062","article-title":"Inhibitory effects of chondroitin sulfate on alpha-amylase activity: a potential hypogly-cemic agent","volume":"184","author":"Pang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.saa.2021.120595_b0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0003-2697(81)90474-7","article-title":"Fluorescence quenching studies with proteins","volume":"114","author":"Eftink","year":"1981","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.saa.2021.120595_b0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.saa.2021.120595_b0105","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/bi00745a020","article-title":"Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules","volume":"12","author":"Lakowicz","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.saa.2021.120595_b0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/j100809a020","article-title":"Oxygen quenching of fluorescence in solution: an experimental study of the diffusion process","volume":"66","author":"Ware","year":"1962","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.saa.2021.120595_b0115","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1021\/bi00514a017","article-title":"Thermodynamics of protein association reactions: forces contributing stability","volume":"20","author":"Ross","year":"1981","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.saa.2021.120595_b0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Prot. Eng."},{"issue":"8","key":"10.1016\/j.saa.2021.120595_b0125","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.saa.2021.120595_b0130","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.saa.2021.120595_b0135","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1080\/07391102.2020.1776157","article-title":"Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies","volume":"39","author":"Gupta","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.saa.2021.120595_b0140","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bjh.16727","article-title":"Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action","volume":"189","author":"Kollias","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.saa.2021.120595_b0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11239-020-02162-z","article-title":"The association between treatment with heparin and survival in patients with Covid-19","volume":"50","author":"Ayerbe","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"4","key":"10.1016\/j.saa.2021.120595_b0150","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.saa.2021.120595_b0155","doi-asserted-by":"crossref","unstructured":"I. Capila, R.J. Linhardt, Heparin-protein interactions, Angew. Chem. Int. Ed. 41 (2002) 390\u2013412, doi: 10.1002\/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b.","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B"},{"issue":"Suppl 1","key":"10.1016\/j.saa.2021.120595_b0160","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0167-5273(16)12004-2","article-title":"Old and new applications of non-anticoagulant heparin","volume":"212","author":"Cassinelli","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.saa.2021.120595_b0165","doi-asserted-by":"crossref","unstructured":"B.S. Schwartz, Heparin: what is it? How does it work? Clin. Cardiol. 13 (1990) VI12\u201315.","DOI":"10.1002\/clc.1990.13.s6.12"},{"key":"10.1016\/j.saa.2021.120595_b0170","doi-asserted-by":"crossref","unstructured":"T.M. Clausen, D.R. Sandoval, C.B. Spliid, J. Pihl, H.R. Perrett, C.D. Painter, A. Narayanan, S.A. Majowicz, E.M. Kwong, R.N. McVicar, B.E. Thacker, C.A. Glass, Z. Yang, J.L. Torres, G.J. Golden, P.L. Bartels, R.N. Porell, A.F. Garretson, L. Laubach, J. Feldman, X. Yin, Y. Pu, B.M. Hauser, T.M. Caradonna, B.P. Kellman, C. Martino, PLSM. Gordts, S.K. Chanda, A.G. Schmidt, K. Godula, S.L. Leibel, J. Jose, K.D. Corbett, A.B. Ward, A.F. Carlin, J.D. Esko, SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2, Cell 183 (2020) 1043\u2013057, doi: 10.1016\/j.cell.2020.09.033.","DOI":"10.1016\/j.cell.2020.09.033"},{"key":"10.1016\/j.saa.2021.120595_b0175","doi-asserted-by":"crossref","unstructured":"R.D. Lopes, P.G.M. de Barros E Silva, R.H.M. Furtado, A.V.S. Macedo, B. Bronhara, L.P. Damiani, L.M. Barbosa, J. de Aveiro Morata, E. Ramacciotti, P. de Aquino Martins, A.L. de Oliveira, V.S. Nunes, L.E.F. Ritt, A.T. Rocha, L. Tramujas, S.V. Santos, D.R.A. Diaz, L.S. Viana, L.M.G. Melro, M.S. de Alc\u00e2ntara Chaud, E.L. Figueiredo, F.C. Neuenschwander, M.D.A. Dracoulakis, R.G.S.D. Lima, V.C. de Souza Dantas, A.C.S. Fernandes, O.C.E. Gebara, M.E. Hernandes, D.A.R. Queiroz, V.C. Veiga, M.F. Canesin, L.M. de Faria, G.S. Feitosa-Filho, M.B. Gazzana, I.L. Liporace, A. de Oliveira Twardowsky, L.N. Maia, F.R. Machado, A. de Matos Soeiro, G.E. Concei\u00e7\u00e3o-Souza, L. Armaganijan, P.O. Guimar\u00e3es, R R.G. osa, L.C.P. Azevedo, J.H. Alexander, A. Avezum, A.B. Cavalcanti, O. Berwanger, ACTION Coalition COVID-19 Brazil IV Investigators, Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial, Lancet 397 (2021) 2253\u20132263, doi: 10.1016\/S0140-6736(21)01203-4.","DOI":"10.1016\/S0140-6736(21)01203-4"},{"issue":"9","key":"10.1016\/j.saa.2021.120595_b0180","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1039\/D0FO02017F","article-title":"Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2","volume":"11","author":"Song","year":"2020","journal-title":"Food Funct."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142521011720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142521011720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:54:31Z","timestamp":1761357271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142521011720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":36,"alternative-id":["S1386142521011720"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2021.120595","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin interacts with the main protease of SARS-CoV-2 and inhibits its activity","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2021.120595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120595"}}